Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Mullen

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
Antisense oligonucleotide targeting of Raf-1: importance of raf-1 mRNA expression levels and raf-1-dependent signaling in determining growth response in ovarian cancerPeter Mullen, Fiona McPhillips, Kenneth MacLeod, et al.
European Journal of Cancer (Oxford, England : 1990)|February 22, 2011
Phosphoprotein pathway profiling of ovarian carcinoma for the identification of potential new targets for therapyDana Faratian, Inhwa Um, Danielle S Wilson, et al.
The FEBS Journal|October 15, 2013
Human tissue in systems medicinePeter D Caie, Klaas Schuur, Anca Oniscu, et al.
Cancers|January 28, 2026
Long-Read Spatial Transcriptomics of Patient-Derived Clear Cell Renal Cell Carcinoma Organoids Identifies Heterogeneity and Transcriptional Remodelling Following NUC-7738 TreatmentHazem Abdullah, Ying Zhang, Kathryn Kirkwood, et al.
Oncotarget|June 16, 2016
A signaling visualization toolkit to support rational design of combination therapies and biomarker discovery: SiViTJames L Bown, Mark Shovman, Paul Robertson, et al.
Biotechnology and Applied Biochemistry|June 11, 2013
Experimental characterization of next-generation expanded-bed adsorbents for capture of a recombinant protein expressed in high-cell-density yeast fermentationWilliam Kelly, Phillip Garcia, Stefanie McDermott, et al.
Biochemical Society Transactions|August 12, 2014
Novel flavonoids as anti-cancer agents: mechanisms of action and promise for their potential application in breast cancerCarlos Martinez-Perez, Carol Ward, Graeme Cook, et al.
Oncotarget|December 20, 2015
The role of HDAC2 in chromatin remodelling and response to chemotherapy in ovarian cancerRui Huang, Simon P Langdon, Matthew Tse, et al.
Plos One|September 13, 2011
Sprouty 2 is an independent prognostic factor in breast cancer and may be useful in stratifying patients for trastuzumab therapyDana Faratian, Andrew H Sims, Peter Mullen, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 17, 2011
Model-based global sensitivity analysis as applied to identification of anti-cancer drug targets and biomarkers of drug resistance in the ErbB2/3 networkGalina Lebedeva, Anatoly Sorokin, Dana Faratian, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
Antisense oligonucleotide targeting of Raf-1: importance of raf-1 mRNA expression levels and raf-1-dependent signaling in determining growth response in ovarian cancerPeter Mullen, Fiona McPhillips, Kenneth MacLeod, et al.
European Journal of Cancer (Oxford, England : 1990)|February 22, 2011
Phosphoprotein pathway profiling of ovarian carcinoma for the identification of potential new targets for therapyDana Faratian, Inhwa Um, Danielle S Wilson, et al.
The FEBS Journal|October 15, 2013
Human tissue in systems medicinePeter D Caie, Klaas Schuur, Anca Oniscu, et al.
Cancers|January 28, 2026
Long-Read Spatial Transcriptomics of Patient-Derived Clear Cell Renal Cell Carcinoma Organoids Identifies Heterogeneity and Transcriptional Remodelling Following NUC-7738 TreatmentHazem Abdullah, Ying Zhang, Kathryn Kirkwood, et al.
Oncotarget|June 16, 2016
A signaling visualization toolkit to support rational design of combination therapies and biomarker discovery: SiViTJames L Bown, Mark Shovman, Paul Robertson, et al.
Biotechnology and Applied Biochemistry|June 11, 2013
Experimental characterization of next-generation expanded-bed adsorbents for capture of a recombinant protein expressed in high-cell-density yeast fermentationWilliam Kelly, Phillip Garcia, Stefanie McDermott, et al.
Biochemical Society Transactions|August 12, 2014
Novel flavonoids as anti-cancer agents: mechanisms of action and promise for their potential application in breast cancerCarlos Martinez-Perez, Carol Ward, Graeme Cook, et al.
Oncotarget|December 20, 2015
The role of HDAC2 in chromatin remodelling and response to chemotherapy in ovarian cancerRui Huang, Simon P Langdon, Matthew Tse, et al.
Plos One|September 13, 2011
Sprouty 2 is an independent prognostic factor in breast cancer and may be useful in stratifying patients for trastuzumab therapyDana Faratian, Andrew H Sims, Peter Mullen, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 17, 2011
Model-based global sensitivity analysis as applied to identification of anti-cancer drug targets and biomarkers of drug resistance in the ErbB2/3 networkGalina Lebedeva, Anatoly Sorokin, Dana Faratian, et al.
Pageof 5